Katsunori Yokoi

Department Of R&D
Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Antiseizure therapy attenuates cognitive decline in Alzheimer's disease: A retrospective cohort study.

Antiseizure therapy attenuates cognitive decline in Alzheimer's disease: A retrospective cohort study.

Journal: Journal of Alzheimer's disease : JAD

Published: January 22, 2026

Factors associated with epileptiform discharges in patients visiting a memory clinic: A retrospective study.

Factors associated with epileptiform discharges in patients visiting a memory clinic: A retrospective study.

Journal: Epilepsy & behavior reports

Published: November 09, 2025

Modulation of middle-latency somatosensory evoked magnetic field waveforms associated with the pathophysiological states of Alzheimer's disease.

Modulation of middle-latency somatosensory evoked magnetic field waveforms associated with the pathophysiological states of Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: September 26, 2025

A case series on the effect of lidocaine injection on camptocormia in Parkinson disease: Determination of injection site using muscle hardness tester.

A case series on the effect of lidocaine injection on camptocormia in Parkinson disease: Determination of injection site using muscle hardness tester.

Journal: Medicine

Published: July 29, 2025

A Case Series on the Effectiveness of Abdominal Belts for Postural Blood Pressure Disorders in Parkinson's Disease.

A Case Series on the Effectiveness of Abdominal Belts for Postural Blood Pressure Disorders in Parkinson's Disease.

Journal: Cureus

Published: June 15, 2025

Transient Anti-Glutamic Acid Decarboxylase (GAD) Antibody Positivity and Insulin Secretion Reduction After IVIg in Type 2 Diabetes Mellitus.

Transient Anti-Glutamic Acid Decarboxylase (GAD) Antibody Positivity and Insulin Secretion Reduction After IVIg in Type 2 Diabetes Mellitus.

Journal: Cureus

Published: April 10, 2025

Phase II pilot randomized trial of zonisamide for disease modification in prodromal Lewy body disease.

Phase II pilot randomized trial of zonisamide for disease modification in prodromal Lewy body disease.

Journal: NPJ Parkinson's disease

Published: February 24, 2025

Japanese participant data from three gantenerumab trials in early Alzheimer's disease.

Japanese participant data from three gantenerumab trials in early Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 25, 2024

Plasma biomarkers of neurodegeneration in patients and high risk subjects with Lewy body disease.

Plasma biomarkers of neurodegeneration in patients and high risk subjects with Lewy body disease.

Journal: NPJ Parkinson's disease

Published: January 09, 2024

Analysis of spontaneous speech in Parkinson's disease by natural language processing.

Analysis of spontaneous speech in Parkinson's disease by natural language processing.

Journal: Parkinsonism & related disorders

Published: February 20, 2023

Too much is too little: Estimating the optimal physical activity level for a healthy mental state.

Too much is too little: Estimating the optimal physical activity level for a healthy mental state.

Journal: Frontiers in psychology

Published: September 15, 2022

Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis.

Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis.

Journal: NPJ Parkinson's disease

Published: August 25, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026